Kong Y, Li S, Wang K, Zhu B, Yuan Y, Li M
Biomolecules. 2023; 13(3.
PMID: 36979477
PMC: 10046098.
DOI: 10.3390/biom13030543.
Christine A, Park M, Song S, Song M
Exp Mol Med. 2022; 54(11):1814-1821.
PMID: 36385557
PMC: 9723170.
DOI: 10.1038/s12276-022-00887-w.
Li M, Yuan Y, Zhu B, Wang K, Fung W, Zhou J
Genes (Basel). 2022; 13(5).
PMID: 35627212
PMC: 9140558.
DOI: 10.3390/genes13050827.
Yu W, Zhang Y, Li M, Yang Z, Fung W, Zhao P
BMC Bioinformatics. 2022; 23(1):193.
PMID: 35610583
PMC: 9128296.
DOI: 10.1186/s12859-022-04721-y.
Huang L, Sun L, Li X, Li S, Zhang T, Zhang Z
Br J Ophthalmol. 2022; 107(8):1151-1155.
PMID: 35361573
PMC: 10359507.
DOI: 10.1136/bjophthalmol-2021-320084.
A statistical measure for the skewness of X chromosome inactivation for quantitative traits and its application to the MCTFR data.
Li B, Yu W, Zhou J
BMC Genom Data. 2021; 22(1):24.
PMID: 34215184
PMC: 8254321.
DOI: 10.1186/s12863-021-00978-z.
Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics.
Migliore L, Nicoli V, Stoccoro A
Biomedicines. 2021; 9(6).
PMID: 34200989
PMC: 8228628.
DOI: 10.3390/biomedicines9060652.
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression.
Park M, Yao Y, Xia W, Setijono S, Kim J, Vila I
Nat Commun. 2019; 10(1):636.
PMID: 30733438
PMC: 6367354.
DOI: 10.1038/s41467-019-08481-x.
A statistical measure for the skewness of X chromosome inactivation based on case-control design.
Wang P, Zhang Y, Wang B, Li J, Wang Y, Pan D
BMC Bioinformatics. 2019; 20(1):11.
PMID: 30616589
PMC: 6323862.
DOI: 10.1186/s12859-018-2587-2.
Sex disparity in cancer: roles of microRNAs and related functional players.
Care A, Bellenghi M, Matarrese P, Gabriele L, Salvioli S, Malorni W
Cell Death Differ. 2018; 25(3):477-485.
PMID: 29352271
PMC: 5864217.
DOI: 10.1038/s41418-017-0051-x.
Stochastic epigenetic mutations (DNA methylation) increase exponentially in human aging and correlate with X chromosome inactivation skewing in females.
Gentilini D, Garagnani P, Pisoni S, Bacalini M, Calzari L, Mari D
Aging (Albany NY). 2015; 7(8):568-78.
PMID: 26342808
PMC: 4586102.
DOI: 10.18632/aging.100792.
The relationship between skewed X chromosome inactivation and the prognosis of Graves' and Hashimoto's diseases.
Ishido N, Inoue N, Watanabe M, Hidaka Y, Iwatani Y
Thyroid. 2014; 25(2):256-61.
PMID: 25338305
PMC: 4322037.
DOI: 10.1089/thy.2014.0318.
The haplotype of three polymorphisms in the promoter region impacts survival in breast cancer patients.
Heubner M, Kimmig R, Aktas B, Siffert W, Frey U
Oncol Lett. 2014; 7(6):2007-2012.
PMID: 24932280
PMC: 4049675.
DOI: 10.3892/ol.2014.1983.
X chromosome regulation: diverse patterns in development, tissues and disease.
Deng X, Berletch J, Nguyen D, Disteche C
Nat Rev Genet. 2014; 15(6):367-78.
PMID: 24733023
PMC: 4117651.
DOI: 10.1038/nrg3687.
High frequency of the X-chromosome inactivation in young female patients with high-grade glioma.
Li G, Zhang Z, Jin T, Liang H, Tu Y, Gong L
Diagn Pathol. 2013; 8:101.
PMID: 23782947
PMC: 3744161.
DOI: 10.1186/1746-1596-8-101.
Skewed X-chromosome inactivation in patients with esophageal carcinoma.
Li G, Jin T, Liang H, Tu Y, Zhang W, Gong L
Diagn Pathol. 2013; 8:55.
PMID: 23556484
PMC: 3640911.
DOI: 10.1186/1746-1596-8-55.
Inactivation of X-linked tumor suppressor genes in human cancer.
Liu R, Kain M, Wang L
Future Oncol. 2012; 8(4):463-81.
PMID: 22515449
PMC: 4369797.
DOI: 10.2217/fon.12.26.
Characterization of human invariant natural killer T cells expressing FoxP3.
Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew C
Int Immunol. 2011; 23(8):473-84.
PMID: 21708895
PMC: 8139402.
DOI: 10.1093/intimm/dxr040.
IGF2: epigenetic regulation and role in development and disease.
Chao W, DAmore P
Cytokine Growth Factor Rev. 2008; 19(2):111-20.
PMID: 18308616
PMC: 2314671.
DOI: 10.1016/j.cytogfr.2008.01.005.
